Clinical characteristics and follow-up of subjects with non-insulin-dependent diabetes mellitus diagnosed by screening

1996 ◽  
Vol 13 (3) ◽  
pp. 75-78 ◽  
Author(s):  
MJ Davies ◽  
A Grenfell ◽  
JL Day
1996 ◽  
Vol 10 (3) ◽  
pp. 154-159 ◽  
Author(s):  
Renata Lorini ◽  
M. Serenella Scotta ◽  
Luigia Cortona ◽  
M. Antonietta Avanzini ◽  
Letizia Vitali ◽  
...  

1997 ◽  
Vol 68 (4) ◽  
pp. 328-334 ◽  
Author(s):  
Arthur B. Novaes ◽  
Maristela A.P. Silva ◽  
Eraldo L. Batista ◽  
Beatriz A. dos Anjos ◽  
Arthur B. Novaes ◽  
...  

Author(s):  
Waqas T Qureshi ◽  
Mohammad Zaidan ◽  
Mohammad Alqarqaz ◽  
David Lanfear ◽  
Fatima Khalid ◽  
...  

Background: Exercise capacity has been shown to predict outcomes in the general population. However, the prognostic value of Exercise capacity in patients with insulin dependent diabetes mellitus (IDDM) and non insulin dependent diabetes mellitus (NIDDM) has not been extensively evaluated. Methods: We included 10768 consecutive diabetic patients (3600 (33%) IDDM and 7168 NIDDM (67%)) who underwent exercise testing between 1991 and 2008. Baseline characteristics and exercise data were collected prospectively at the time of testing including Metabolic Equivalents (METS). The primary endpoint is all cause mortality confirmed by the social security death index. Results: Patents with IDDM were older, more often females (46% vs. 41%) with higher prevalence of hypertension (83% vs. 77%) and prior coronary disease (21% vs. 17%). Patients with NIDDM achieved more than 10 METS more often (36% vs. 30%, p<0.0001). After a median follow-up duration of 6.4 years (Range 1-18 years), 2143 patients (20%) died. Kaplan Meier survival curves are shown below. Using Multivariable Cox Hazard Proportional Analysis, IDDM (Hazard ratio 1.45, 95% CI 1.3 -1.6, p<0.0001 (in comaprison to NIDDM)) and METS achieved (HR 0.82, 95% CI 0.80-0.83, p<0.0001 per METS achieved) were associated with decreased survival. Conclusions: In this large cohort of diabetic patients, decreased Exercise capacity is independently associated with decreased survival over long follow-up duration.


1998 ◽  
Vol 19 (9) ◽  
pp. 619-623 ◽  
Author(s):  
Janak A. Mehta ◽  
Christopher Brown ◽  
Naomi Sargeant

Five patients (three with insulin dependent diabetes mellitus (IDDM), one with noninsulin dependent diabetes mettlitus (NIDDM), and one with hereditary sensorimotor neuropathy (HSMN)) with stage 1 Charcot's neuroarthropathy involving the midfoot and or subtalar and ankle joints were fitted with a Charcot restraint orthotic walker (CROW). The rationale for this orthotic management was to maintain a plantigrade foot for ambulation and to protect the joints and skin by the uniform transfer or distribution of weight over the foot until the time when the pathology reached the stage of coalescence. The patients were able to fully bear weight and to ambulate with the CROW. All patients noted varying measures of improvement in symptoms and function at an average 12-month follow-up. The CROW is a useful orthosis in the armamentarium for treating neuroarthropathy of the pedal joints.


Sign in / Sign up

Export Citation Format

Share Document